Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genome and Epigenome Editing to Treat Disorders of the Hematopoietic System

15 Aug 2017

Abstract excerpt

The possibility of editing complex genomes in a targeted fashion has revolutionized basic research as well as biomedical and biotechnological applications in the last 5 years. The targeted introduction of genetic changes has allowed researchers to create smart model systems for basic research, bio-engineers to modify crops and farm animals, and translational scientists to develop novel treatment approaches for...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CAR-T cell therapy research
Share to CRISPR and Genetic Engineering
Share to Innovation and Socioeconomic Development

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 28806883
DOI: 10.1089/hum.2017.149

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genome and Epigenome Editing to Treat Disorders of the Hematopoietic SystemPMID 28806883Read ↗

Genome-editing Technologies for Gene and Cell TherapySemantic proximity Read ↗

Gene Editing of Human Hematopoietic Stem and Progenitor Cells: Promise and Potential HurdlesSemantic proximity Read ↗

A Curative DNA Code for Hematopoietic DefectsSemantic proximity Read ↗

In Vivo Hematopoietic Stem Cell Genome Editing: Perspectives and LimitationsSemantic proximity Read ↗

Therapy Development by Genome Editing of Hematopoietic Stem CellsSemantic proximity Read ↗

In Vivo Genome Editing as a Therapeutic Approach.Semantic proximity Read ↗

Current landscape of gene‐editing technology in biomedicine: Applications, advantages, challenges, and perspectivesSemantic proximity Read ↗

The changing landscape of gene editing in hematopoietic stem cells: a step towards Cas9 clinical translationSemantic proximity Read ↗

Using Gene Editing Approaches to Fine-Tune the Immune SystemSemantic proximity Read ↗

Genome Editing Therapy for the Blood: Ex Vivo Success and In Vivo ProspectsSemantic proximity Read ↗

Gene Editing for the Treatment of Primary Immunodeficiency DiseasesSemantic proximity Read ↗

CRISPR to fix bad blood: a new tool in basic and clinical hematologySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.